Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion

Clinical trial NCT00913744 · COMPLETED

Trial details

NCT number: NCT00913744
Sponsor: ThromboGenics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Exudative Age-Related Macular Degeneration Focal Vitreomacular Adhesion

Start date: 2010-01-01
Primary completion: 2012-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.